Aperio Group’s Aratana Therapeutics, Inc. PETX Stock Holding History

Aperio Group’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-9,895	Closed	-$51K	–	3026
2019 Q2	$51K	Buy	+9,895	New	+$44.5K	﹤0.01%	2529
2019 Q1	–	Sell	-11,864	Closed	-$73K	–	2325
2018 Q4	$73K	Buy	+11,864	New	+$72.4K	﹤0.01%	2248

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Aperio Group's PETX Position: Q3 2019 in Review

Aperio Group sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 9,895 shares — an estimated $51K sold.

Aperio Group first reported a position in PETX in Q4 2018 and held it in 2 quarters. The position peaked at $73K in Q4 2018. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Aperio Group reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Aperio Group sold 9,895 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $51K.
Aperio Group first reported a position in Aratana Therapeutics, Inc. in Q4 2018 and held it in 2 quarters.
Aperio Group's Aratana Therapeutics, Inc. position peaked at $73K in Q4 2018.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.